Quantitation of nanoparticle accumulation in flow using optimized microfluidic chambers.
BACKGROUND
The vascular cell adhesion molecule-1 (VCAM-1) targeting peptide sequence, VHPKQHR, is a promising moiety for targeting atherosclerosis through incorporation into nanoparticles such as dendrimers and liposomes.


OBJECTIVE
We aim to develop VCAM-1-targeted nanoparticles that effectively accumulate on the endothelium under shear conditions and to develop robust microfluidic chambers able to house sufficient cells for flow cytometric measurements.


METHODS
Carboxyfluorescein-labeled monomeric VHP-peptide, tetrameric VHP-dendrimers (bisbidentate or radial architecture, with or without N-terminal acetylation) and VHP-peptide liposomes were prepared. Human umbilical vein endothelial cells were treated with nanoparticles under 0 or 2.9 dyne/cm(2) shear, and particle binding was quantified. Flow chambers cured at various temperatures, with or without glass backings were fabricated, characterized for deformation and applied in experiments.


RESULTS
Although liposomes accumulated with highest efficiency, dendrimers also demonstrated specific binding. N-terminal acetylation significantly reduced dendrimer binding, and despite shorter movement range, bisbidentate dendrimers outperformed radial dendrimers, suggesting multiple epitope presence within its estimated arm-span of 57 Å. Under shear, while liposome binding increased 300%, dendrimer binding to cells decreased 65%. Through higher temperature curing and glass backing insertion, polydimethylsiloxane flow chambers maintaining rectangular cross-section with aspect-ratio as low as 1:111 were achieved.


CONCLUSIONS
Optimized dendrimers and liposomal nanocarriers specifically accumulated onto cells within microfluidic chambers.
Department of Biomedical Engineering, University of California , Davis, CA , USA.
J
J
Kusunose
M K J
MK
Gagnon
J W
JW
Seo
K W
KW
Ferrara
D002478:Cells, Cultured; D050091:Dendrimers / Q000378:metabolism; D004727:Endothelium / Q000378:metabolism*; D061307:Human Umbilical Vein Endothelial Cells / Q000378:metabolism; D006801:Humans; D008081:Liposomes / Q000378:metabolism; D044085:Microfluidics / Q000379:methods; D053758:Nanoparticles / Q000378:metabolism*; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism*
D050091:Dendrimers; D008081:Liposomes; D019010:Vascular Cell Adhesion Molecule-1